SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Aurora Biosciences (ABSC)
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: tuck who wrote (294)2/17/2000 3:31:00 PM
From: Cooters   of 359
 
Aurora Biosciences Rated New `Strong Buy' at Thomas Weisel

--From AtHome News-- Cooters

Princeton, New Jersey, Feb. 17 (Bloomberg Data) -- Aurora Biosciences Corp. (ABSC US) was rated new ``strong buy' in new coverage by analyst Scott R Greenstone at Thomas Weisel Partners. The price target is $95.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News